Nutrien Management
Management criteria checks 3/4
Nutrien's CEO is Ken Seitz, appointed in Jan 2022, has a tenure of 4.33 years. total yearly compensation is $9.44M, comprised of 9.3% salary and 90.7% bonuses, including company stock and options. directly owns 0.009% of the company’s shares, worth CA$4.26M. The average tenure of the management team and the board of directors is 1 years and 8.3 years respectively.
Key information
Ken Seitz
Chief executive officer
US$9.4m
Total compensation
| CEO salary percentage | 9.28% |
| CEO tenure | 4.3yrs |
| CEO ownership | 0.009% |
| Management average tenure | 1yrs |
| Board average tenure | 8.3yrs |
Recent management updates
Recent updates
Narrative Update • May 03
NTR: Tighter Fertilizer Markets And DOJ Probe Will Shape Future Returns
The updated analyst price target for Nutrien reflects a small decrease of about CA$0.26. Analysts are balancing slightly softer implied revenue growth and a marginally higher discount rate against firmer profit margin assumptions and a modestly lower future P/E multiple.
Narrative Update • Apr 19
NTR: Tighter Fertilizer Markets And DOJ Probe Will Shape Balanced Outlook
The analyst price target for Nutrien has risen by CA$4.18. Analysts attribute this change to updated assumptions for slightly stronger revenue growth, higher profit margins, and a lower future P/E multiple, reflecting the recent wave of higher sector targets and tighter global fertilizer markets.Narrative Update • Apr 04
NTR: Tighter Fertilizer Markets And DOJ Probe Will Pressure Future Returns
Analysts have nudged the fair value estimate for Nutrien higher to CA$95.41. This reflects a modestly lower discount rate, slightly firmer long term margin assumptions, and updated sector P/E comparisons that incorporate a wave of recent price target increases tied to tighter fertilizer markets and higher commodity pricing expectations.Narrative Update • Mar 21
NTR: Higher Fertilizer Pricing And DOJ Probe Will Shape Share Performance
Analysts have lifted the average Nutrien price target by roughly CA$31 to around CA$95, citing stronger fertilizer pricing, higher expected profit margins and support for elevated sector valuation multiples, despite more cautious views on volume growth. Analyst Commentary Recent research on Nutrien largely centers on fertilizer pricing, geopolitical risks and the earnings impact of tighter nitrogen and potash markets.Narrative Update • Mar 07
NTR: Nutrient Pricing, Portfolio Actions And DOJ Probe Will Shape Balanced Outlook
The analyst price target for Nutrien has increased to CA$101.07 from CA$96.56, as analysts factor in firmer nutrient pricing expectations, potential nitrogen upside tied to recent geopolitical events, and company-specific portfolio actions that they view as supportive of earnings stability and cash generation. Analyst Commentary Recent research points to a broadly constructive tone around Nutrien, with multiple firms updating models after the Q4 report and adjusting price targets on the back of nutrient pricing assumptions, portfolio moves, and expected cash generation.Narrative Update • Feb 21
NTR: Firmer Nutrient Pricing And Potash Supply Risks Will Shape Balanced Returns
Our updated fair value estimate for Nutrien edges higher to CA$96.56 from CA$91.99, reflecting a series of analyst price target increases tied to refreshed models after recent results, stronger assumed profit margins, and expectations that nutrient pricing holds firmer for longer, even as some remain cautious about future potash supply. Analyst Commentary Street research on Nutrien has been active, with several firms revisiting their models and adjusting price targets around recent and upcoming quarterly results.Narrative Update • Feb 07
NTR: Reassessed P/E And Farm Headwinds Will Shape Balanced Returns Ahead
Analysts have raised our Nutrien fair value estimate to $91.99 from $88.43, as recent price target increases and rating changes suggest a reassessment of the stock's risk profile, growth outlook, and appropriate future P/E multiple. Analyst Commentary Recent Street research on Nutrien has become more constructive, with several firms increasing price targets or improving ratings while others remain cautious on end market conditions and sector headwinds.
Narrative Update • Jan 23
NTR: Higher Fertilizer Pricing And Buybacks Will Support Future Upside
Our analyst price target for Nutrien edges slightly lower to about $112.49 from $113.03, as analysts weigh mixed sector commentary on fertilizer and agriculture markets against recent target adjustments and an updated future P/E assumption of roughly 20.2x. Analyst Commentary Recent Street research on Nutrien reflects mixed sector views but a generally supportive tone on the company, with several bullish analysts adjusting targets and ratings while acknowledging a more cautious backdrop for fertilizers and agriculture.Narrative Update • Jan 09
NTR: Fertilizer Cycle Concerns Will Pressure Shares Despite Recent Buybacks
Narrative Update Analysts have nudged their consolidated price target for Nutrien down by about $2 to $64. This reflects updated views that factor in more cautious fertilizer and agriculture setups, modestly lower assumed revenue growth, a slightly higher profit margin profile, and a reduced future P/E multiple in their models.Narrative Update • Dec 21
NTR Is Expected To Benefit From Potential Upside In Fertilizer Pricing
Analysts have modestly reduced their price target on Nutrien to approximately $113 from about $97, citing a tougher near term backdrop for farmers, slightly lower growth and margin expectations, and a more balanced risk reward profile after the stock's strong run. Analyst Commentary Recent Street research reflects a mixed but generally constructive stance on Nutrien, with several firms trimming price targets modestly while maintaining positive ratings.Narrative Update • Dec 07
NTR: Portfolio Streamlining And Farm Headwinds Will Shape Balanced Returns Ahead
Analysts have modestly reduced their price expectations for Nutrien, trimming the target by a low single digit dollar amount to reflect a tougher near term farm income backdrop, portfolio streamlining impacts, and a more balanced risk reward view despite solid recent execution. Analyst Commentary Street research on Nutrien reflects a constructive long term view, tempered by nearer term caution around farm fundamentals, commodity pricing and the impact of recent portfolio moves.Narrative Update • Nov 23
NTR: Portfolio Streamlining And Asset Sales Will Drive Sector Outperformance Ahead
Nutrien's analyst price target has been modestly reduced by $0.21 to $88.43. Analysts cite ongoing sector headwinds, including weaker crop prices, portfolio adjustments, and a more balanced risk-reward outlook, despite solid recent performance.Narrative Update • Nov 07
NTR: Portfolio Streamlining and Supply Tightness Will Shape Upside Amid Sector Scrutiny
Nutrien’s average analyst price target has edged slightly lower in recent weeks, as analysts weigh a modestly improving profit margin and fair value estimate against easing revenue growth and persistent caution over the agricultural cycle. Analyst Commentary Recent analyst activity around Nutrien highlights both opportunities and challenges for the company as it navigates ongoing market volatility and shifting sector dynamics.Narrative Update • Oct 24
Shifting Market Trends Will Shape Fertilizer Demand Amid Agricultural Cycle Uncertainty
Nutrien's analyst price targets have recently edged lower by $1 to $2 per share, as analysts cite cautious earnings expectations, a more balanced risk-reward profile, and the impact of portfolio adjustments on future performance. Analyst Commentary Recent Street research highlights a divided outlook among analysts covering Nutrien, reflecting both positive and cautionary perspectives as the company navigates its next phase of growth and portfolio transformation.Narrative Update • Oct 09
Global Food Demand And Precision Ag Will Secure Fertilizer Success
Analysts have modestly raised their price target for Nutrien, increasing it by approximately $1.38 to reflect updated earnings projections and evolving outlooks for fertilizer market conditions. Analyst Commentary Recent street research reflects a mixed outlook on Nutrien's growth trajectory, valuation, and near-term execution capacity.Analysis Article • Sep 08
With Nutrien Ltd. (TSE:NTR) It Looks Like You'll Get What You Pay For
Nutrien Ltd.'s ( TSE:NTR ) price-to-earnings (or "P/E") ratio of 20.1x might make it look like a sell right now...Analysis Article • Aug 08
Nutrien Ltd. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Shareholders might have noticed that Nutrien Ltd. ( TSE:NTR ) filed its second-quarter result this time last week. The...Analysis Article • Jul 16
Nutrien (TSE:NTR) Has Some Way To Go To Become A Multi-Bagger
What are the early trends we should look for to identify a stock that could multiply in value over the long term? One...Analysis Article • Jul 03
A Look At The Fair Value Of Nutrien Ltd. (TSE:NTR)
Key Insights Using the 2 Stage Free Cash Flow to Equity, Nutrien fair value estimate is CA$98.09 Current share price of...
New Narrative • Feb 09
Accelerated Efficiency And Expanded Potash And Nitrogen Output Will Strengthen Future Operations
Accelerated operational efficiency and strategic sales expansion may enhance margins and boost revenue without significant new capital expenditure.CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Mar 31 2026 | n/a | n/a | US$2b |
| Dec 31 2025 | US$9m | US$876k | US$2b |
| Sep 30 2025 | n/a | n/a | US$2b |
| Jun 30 2025 | n/a | n/a | US$1b |
| Mar 31 2025 | n/a | n/a | US$527m |
| Dec 31 2024 | US$8m | US$863k | US$674m |
| Sep 30 2024 | n/a | n/a | US$733m |
| Jun 30 2024 | n/a | n/a | US$790m |
| Mar 31 2024 | n/a | n/a | US$845m |
| Dec 31 2023 | US$7m | US$852k | US$1b |
| Sep 30 2023 | n/a | n/a | US$2b |
| Jun 30 2023 | n/a | n/a | US$4b |
| Mar 31 2023 | n/a | n/a | US$7b |
| Dec 31 2022 | US$9m | US$829k | US$8b |
| Sep 30 2022 | n/a | n/a | US$8b |
| Jun 30 2022 | n/a | n/a | US$7b |
| Mar 31 2022 | n/a | n/a | US$4b |
| Dec 31 2021 | US$4m | US$677k | US$3b |
| Sep 30 2021 | n/a | n/a | US$2b |
| Jun 30 2021 | n/a | n/a | US$964m |
| Mar 31 2021 | n/a | n/a | US$621m |
| Dec 31 2020 | US$5m | US$596k | US$459m |
| Sep 30 2020 | n/a | n/a | US$95m |
| Jun 30 2020 | n/a | n/a | US$823m |
| Mar 31 2020 | n/a | n/a | US$916m |
| Dec 31 2019 | US$3m | US$137k | US$992m |
Compensation vs Market: Ken's total compensation ($USD9.44M) is about average for companies of similar size in the Canadian market ($USD7.49M).
Compensation vs Earnings: Ken's compensation has been consistent with company performance over the past year.
CEO
Ken Seitz (55 yo)
4.3yrs
Tenure
US$9,437,234
Compensation
Mr. Kenneth A. Seitz, also known as Ken, is Director of The Fertilizer Institute. Mr. Seitz is Chief Executive Officer, Non-Independent Director and President of Nutrien Ltd. from August 8, 2022.He served...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 4.3yrs | US$9.44m | 0.0091% CA$ 4.3m | |
| Executive VP & CFO | 1.8yrs | US$3.56m | 0.0075% CA$ 3.5m | |
| Executive VP of External Affairs | 6.3yrs | US$3.25m | 0.0036% CA$ 1.7m | |
| Executive Vice President of Global Sales | less than a year | US$2.82m | 0.0017% CA$ 800.6k | |
| Vice President of Investor Relations | no data | no data | no data | |
| Executive VP of Corporate Development & Chief Strategy Officer | 4.3yrs | no data | 0.0017% CA$ 781.9k | |
| Executive VP of IT & Chief People Officer | 1.9yrs | no data | no data | |
| Head Economist | no data | no data | no data | |
| Senior Vice President of Safety | less than a year | no data | no data | |
| Senior Vice President of Upstream | less than a year | no data | no data | |
| Senior Vice President of Midstream | less than a year | no data | no data | |
| Senior Vice President of Upstream | less than a year | no data | 0.0014% CA$ 655.5k |
1.0yrs
Average Tenure
Experienced Management: NTR's management team is not considered experienced ( 1 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 3.8yrs | US$9.44m | 0.0091% CA$ 4.3m | |
| Independent Director | 8.3yrs | US$300.00k | 0.0011% CA$ 510.4k | |
| Independent Chairman | 8.3yrs | US$550.00k | 0.0029% CA$ 1.3m | |
| Independent Director | 5yrs | US$300.00k | 0.00012% CA$ 56.2k | |
| Independent Director | 8.3yrs | US$325.00k | 0.0050% CA$ 2.3m | |
| Non-Independent Director | 8.3yrs | US$300.00k | 0.0012% CA$ 566.5k | |
| Independent Director | 4yrs | US$316.21k | 0.0010% CA$ 486.9k | |
| Independent Director | 8.3yrs | US$308.79k | 0.00021% CA$ 98.3k | |
| Independent Director | no data | no data | no data | |
| Independent Director | 8.3yrs | US$325.00k | 0.0035% CA$ 1.7m | |
| Independent Director | 5.8yrs | US$300.00k | 0.00017% CA$ 79.6k | |
| Independent Director | 8.3yrs | US$325.00k | 0.0014% CA$ 641.5k |
8.3yrs
Average Tenure
62.5yo
Average Age
Experienced Board: NTR's board of directors are considered experienced (8.3 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/05/12 21:48 |
| End of Day Share Price | 2026/05/12 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Nutrien Ltd. is covered by 52 analysts. 15 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Harriet Li | Accountability Research Corporation |
| Keith Carpenter | ATB Cormark |
| Benjamin Theurer | Barclays |